Categories AlphaGraphs, Earnings, Health Care
AbbVie Q2 2024 adj. profit drops despite higher revenues; results beat
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Thursday announced second-quarter 2024 financial results, reporting a decline in adjusted earnings and an increase in revenues. The numbers exceeded estimates.
The company reported worldwide net revenues of $14.46 billion for the June quarter, up 4.3% from the corresponding period of 2023 and above the market’s projection. All operating segments, except the Eye Care division, registered growth.
Net income, adjusted for special items, declined to $2.65 per share in Q2 from $2.91 per share in the year-ago quarter, but topped expectations. On a reported basis, second-quarter profit was $1.37 billion or $0.77 per share, compared to $2.02 billion or $1.14 per share last year.
Prior Performance
Most Popular
KB Home’s Q3 results expected to benefit from built-to-order model, stable demand
KB Home (NYSE: KBH) has been resilient to challenges like high mortgage rates and the inflation-induced strain on family budgets, while benefitting from the recovery in the housing market. When
Signet Jewelers (SIG) reports lower Q2 2025 sales and adj. profit
Signet Jewelers Limited (NYSE: SIG) has reported a decline in net sales and adjusted earnings for the second quarter of 2025. Same-store sales declined 3.4% during the three months. Net
Adobe reports higher Q3 revenue and earnings; results beat estimates
Design software maker Adobe Inc. (NASDAQ: ADBE) on Thursday reported an increase in third-quarter 2024 revenue and earnings. The results also topped expectations. Third-quarter revenues came in at $5.41 billion,
